Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

The role of elective neck dissection in high-grade parotid malignancy: A hospital-based cohort study.

Harbison RA, Gray AJ, Westling T, Carone M, Rodriguez CP, Futran ND, Cannon RB, Houlton J.

Laryngoscope. 2019 Aug 29. doi: 10.1002/lary.28238. [Epub ahead of print]

PMID:
31468551
2.

The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial.

Weed DT, Zilio S, Reis IM, Sargi Z, Abouyared M, Gomez-Fernandez CR, Civantos FJ, Rodriguez CP, Serafini P.

Front Immunol. 2019 May 31;10:1206. doi: 10.3389/fimmu.2019.01206. eCollection 2019.

3.

Remote Automated Peritoneal Dialysis Management in Colombia.

Bunch A, Vesga JI, Camargo DO, Corzo L, Molano AP, Devia ME, Rios MC, Rodriguez CP, Sanchez R, Rivera AS, Sanabria RM.

Kidney Int Rep. 2019 Mar 29;4(6):873-876. doi: 10.1016/j.ekir.2019.03.017. eCollection 2019 Jun. No abstract available.

4.

Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti-PD-1 Therapy.

Hwang V, Mendez E, Chow LQM, Futran ND, Andersen P, Li R, Divi V, Rodriguez CP.

Laryngoscope. 2019 May 10. doi: 10.1002/lary.27902. [Epub ahead of print]

PMID:
31074843
5.

Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.

Koyfman SA, Ismaila N, Crook D, D'Cruz A, Rodriguez CP, Sher DJ, Silbermins D, Sturgis EM, Tsue TT, Weiss J, Yom SS, Holsinger FC.

J Clin Oncol. 2019 Jul 10;37(20):1753-1774. doi: 10.1200/JCO.18.01921. Epub 2019 Feb 27.

PMID:
30811281
6.

Postoperative Combined Modality Treatment in High Risk Resected Locally Advanced Squamous Cell Carcinomas of the Head and Neck (HNSCC).

Kirtane K, Rodriguez CP.

Front Oncol. 2018 Dec 4;8:588. doi: 10.3389/fonc.2018.00588. eCollection 2018. Review.

7.

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105.

Drilon A, Fu S, Patel MR, Fakih M, Wang D, Olszanski AJ, Morgensztern D, Liu SV, Cho BC, Bazhenova L, Rodriguez CP, Doebele RC, Wozniak A, Reckamp KL, Seery T, Nikolinakos P, Hu Z, Oliver JW, Trone D, McArthur K, Patel R, Multani PS, Ahn MJ.

Cancer Discov. 2019 Mar;9(3):384-395. doi: 10.1158/2159-8290.CD-18-0839. Epub 2018 Nov 28.

PMID:
30487236
8.

The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer.

Harbison RA, Kubik M, Konnick EQ, Zhang Q, Lee SG, Park H, Zhang J, Carlson CS, Chen C, Schwartz SM, Rodriguez CP, Duvvuri U, Méndez E.

JCI Insight. 2018 Jul 26;3(14). pii: 99327. doi: 10.1172/jci.insight.99327. eCollection 2018 Jul 26.

9.

Peripheral Lymphocytes, Obesity, and Metabolic Syndrome in Young Adults: An Immunometabolism Study.

Rodríguez CP, González MC, Aguilar-Salinas CA, Nájera-Medina O.

Metab Syndr Relat Disord. 2018 Sep;16(7):342-349. doi: 10.1089/met.2018.0005. Epub 2018 Jun 29.

PMID:
29957122
10.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.

11.

Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.

Guerriero MK, Redman MW, Baker KK, Martins RG, Eaton K, Chow LQ, Santana-Davila R, Baik C, Goulart BH, Lee S, Rodriguez CP.

Cancer. 2018 Jul 1;124(13):2841-2849. doi: 10.1002/cncr.31407. Epub 2018 Apr 18.

12.

A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma.

Méndez E, Rodriguez CP, Kao MC, Raju S, Diab A, Harbison RA, Konnick EQ, Mugundu GM, Santana-Davila R, Martins R, Futran ND, Chow LQM.

Clin Cancer Res. 2018 Jun 15;24(12):2740-2748. doi: 10.1158/1078-0432.CCR-17-3796. Epub 2018 Mar 13.

13.

Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies.

Rodriguez CP, Martins RG, Baik C, Chow LQ, Santana-Davila R, Goulart BH, Lee S, Eaton KD.

Head Neck. 2018 Mar;40(3):584-589. doi: 10.1002/hed.25020. Epub 2017 Dec 28.

PMID:
29283469
14.

Immunotherapy for Head and Neck Cancer in the Era of Exponentially Increasing Health Care Expenditure.

Santana-Davila R, Rodriguez CP.

Oncologist. 2018 Feb;23(2):147-149. doi: 10.1634/theoncologist.2017-0527. Epub 2017 Nov 30. No abstract available.

15.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.

16.

Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma.

Pellini Ferreira B, Redman M, Baker KK, Martins R, Eaton KD, Chow LQM, Baik CS, Goulart B, Lee SM, Santana-Davila R, Rodriguez CP.

Laryngoscope. 2017 Jul;127(7):1583-1588. doi: 10.1002/lary.26422. Epub 2016 Dec 1.

PMID:
27905113
17.

Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative Outcomes.

McNamara MJ, Adelstein DJ, Allende DS, Bodmann JW, Ives DI, Murthy SC, Raymond D, Raja S, Rodriguez CP, Sohal D, Stephans KL, Videtic GMM, Rybicki LA.

J Gastrointest Cancer. 2017 Jun;48(2):181-189. doi: 10.1007/s12029-016-9881-x.

PMID:
27734205
18.

Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experience.

Araki D, Redman MW, Martins R, Eaton K, Baik C, Chow L, Goulart B, Lee S, Santana-Davila R, Liao J, Parvathaneni U, Laramore G, Futran N, Mendez E, Bhrany A, Rodriguez CP.

Head Neck. 2016 Sep;38(9):1318-23. doi: 10.1002/hed.24437. Epub 2016 Apr 7.

PMID:
27061333
19.

The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimen.

McNamara MJ, Rybicki LA, Sohal D, Allende DS, Videtic GM, Rodriguez CP, Stephans KL, Murthy SC, Raja S, Raymond D, Ives DI, Bodmann JW, Adelstein DJ.

J Gastrointest Oncol. 2016 Apr;7(2):196-205. doi: 10.3978/j.issn.2078-6891.2015.097.

20.

A Broken Heart: Takotsubo Cardiomyopathy.

Vicenty S, Aulet F, Valentín J, Rodríguez CP, Ortiz VM, Figueroa YM, Ortega MM.

Bol Asoc Med P R. 2016;108(1):27-30.

PMID:
29193913
21.

INTERACTIVE MEDICAL CASE. A Painful Subject.

Rodriguez CP, Vaidya A, Tishler LW, Suzuki J.

N Engl J Med. 2015 Dec 24;373(26):e32. doi: 10.1056/NEJMimc1505316. No abstract available.

PMID:
26699187
22.

Salivary Gland Malignancies.

Rodriguez CP, Parvathaneni U, Méndez E, Martins RG.

Hematol Oncol Clin North Am. 2015 Dec;29(6):1145-57. doi: 10.1016/j.hoc.2015.08.002. Epub 2015 Oct 17. Review.

PMID:
26568553
23.

Head and Neck Cancers, Version 1.2015.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M.

J Natl Compr Canc Netw. 2015 Jul;13(7):847-55; quiz 856.

24.

Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Oct;12(10):1454-87.

25.

A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junction.

McNamara MJ, Adelstein DJ, Bodmann JW, Greskovich JF Jr, Ives DI, Mason DP, Murthy SC, Rice TW, Saxton JP, Sohal D, Stephans K, Rodriguez CP, Videtic GM, Rybicki LA.

J Thorac Oncol. 2014 Oct;9(10):1561-7. doi: 10.1097/JTO.0000000000000312.

26.

Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.

Krug LM, Wozniak AJ, Kindler HL, Feld R, Koczywas M, Morero JL, Rodriguez CP, Ross HJ, Bauman JE, Orlov SV, Ruckdeschel JC, Mita AC, Fein L, He X, Hall R, Kawabe T, Sharma S.

Lung Cancer. 2014 Sep;85(3):429-34. doi: 10.1016/j.lungcan.2014.06.008. Epub 2014 Jul 5.

PMID:
25047675
27.

Genomic medicine and targeted therapy for solid tumors.

Stevens EA, Rodriguez CP.

J Surg Oncol. 2015 Jan;111(1):38-42. doi: 10.1002/jso.23699. Epub 2014 Jul 5. Review.

PMID:
25042935
28.

Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial design.

Rodriguez CP, Adelstein DJ, Rybicki LA, Savvides P, Saxton JP, Koyfman SA, Greskovich JF, Yao M, Scharpf J, Lavertu P, Wood BG, Burkey BB, Lorenz RR, Rezaee RP, Zender CA, Ives DI.

Head Neck. 2015 Nov;37(11):1583-9. doi: 10.1002/hed.23794. Epub 2014 Oct 29.

PMID:
24909549
29.

Gefitinib in definitive management of esophageal or gastroesophageal junction cancer: a retrospective analysis of two clinical trials.

Sohal DP, Rice TW, Rybicki LA, Rodriguez CP, Videtic GM, Saxton JP, Murthy SC, Mason DP, Phillips BE, Tubbs RR, Plesec T, McNamara MJ, Ives DI, Bodmann JW, Adelstein DJ.

Dis Esophagus. 2015 Aug-Sep;28(6):547-51. doi: 10.1111/dote.12241. Epub 2014 May 21.

PMID:
24849395
30.

Rhenium solubility in borosilicate nuclear waste glass: implications for the processing and immobilization of technetium-99.

McCloy JS, Riley BJ, Goel A, Liezers M, Schweiger MJ, Rodriguez CP, Hrma P, Kim DS, Lukens WW, Kruger AA.

Environ Sci Technol. 2012 Nov 20;46(22):12616-22. doi: 10.1021/es302734y. Epub 2012 Oct 26.

PMID:
23101883
31.

Cardiac computed tomography angiography in a Puerto Rico population with chest pain: initial experience at HIMA-San Pablo Bayamón.

Rodríguez CP, Rivera del Rio J, Collazo Ornes P.

Bol Asoc Med P R. 2011 Oct-Dec;103(4):10-4.

PMID:
22737824
32.

Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.

Phillips BE, Tubbs RR, Rice TW, Rybicki LA, Plesec T, Rodriguez CP, Videtic GM, Saxton JP, Ives DI, Adelstein DJ.

Dis Esophagus. 2013 Apr;26(3):299-304. doi: 10.1111/j.1442-2050.2012.01369.x. Epub 2012 Jun 7.

PMID:
22676551
33.

Treatment implications of the new lung cancer staging system.

Rodriguez CP.

Cleve Clin J Med. 2012 May;79 Electronic Suppl 1:eS7-eS10. doi: 10.3949/ccjm.79.s2.02.

PMID:
22614969
34.

Cerebral and muscle MRI abnormalities in myotonic dystrophy.

Franc DT, Muetzel RL, Robinson PR, Rodriguez CP, Dalton JC, Naughton CE, Mueller BA, Wozniak JR, Lim KO, Day JW.

Neuromuscul Disord. 2012 Jun;22(6):483-91. doi: 10.1016/j.nmd.2012.01.003. Epub 2012 Jan 30.

35.

Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck.

Rodriguez CP, Adelstein DJ, Rybicki LA, Saxton JP, Lorenz RR, Wood BG, Scharpf J, Ives DI.

Head Neck. 2012 Nov;34(11):1517-23. doi: 10.1002/hed.21971. Epub 2011 Dec 16.

PMID:
22180262
36.

Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly.

Michal SA, Adelstein DJ, Rybicki LA, Rodriguez CP, Saxton JP, Wood BG, Scharpf J, Ives DI.

Head Neck. 2012 Aug;34(8):1147-52. doi: 10.1002/hed.21891. Epub 2011 Oct 22.

PMID:
22021098
37.

A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction.

Adelstein DJ, Rodriguez CP, Rybicki LA, Ives DI, Rice TW.

Invest New Drugs. 2012 Aug;30(4):1684-9. doi: 10.1007/s10637-011-9736-z. Epub 2011 Aug 24.

PMID:
21863238
38.

Intended single-modality management of T1 and T2 tonsillar carcinomas: retrospective comparison of radical tonsillectomy vs radiation from a single institution.

Lamarre ED, Seth R, Lorenz RR, Esclamado R, Adelstein DJ, Rodriguez CP, Saxton J, Scharpf J.

Am J Otolaryngol. 2012 Jan-Feb;33(1):98-103. doi: 10.1016/j.amjoto.2011.02.005. Epub 2011 Jun 22.

PMID:
21696857
39.

Activity of the equine rectus abdominis and oblique external abdominal muscles measured by surface EMG during walk and trot on the treadmill.

Zsoldos RR, Kotschwar A, Kotschwar AB, Rodriguez CP, Peham C, Licka T.

Equine Vet J Suppl. 2010 Nov;(38):523-9. doi: 10.1111/j.2042-3306.2010.00230.x.

PMID:
21059055
40.

OXA-163, an OXA-48-related class D β-lactamase with extended activity toward expanded-spectrum cephalosporins.

Poirel L, Castanheira M, Carrër A, Rodriguez CP, Jones RN, Smayevsky J, Nordmann P.

Antimicrob Agents Chemother. 2011 Jun;55(6):2546-51. doi: 10.1128/AAC.00022-11. Epub 2011 Mar 21.

41.

What is new in the management of salivary gland cancers?

Adelstein DJ, Rodriguez CP.

Curr Opin Oncol. 2011 May;23(3):249-53. doi: 10.1097/CCO.0b013e328344f59c. Review.

PMID:
21330920
42.

Esophagectomy for clinical high-grade dysplasia.

Rice TW, Murthy SC, Mason DP, Rybicki LA, Yerian LM, Dumot JA, Rodriguez CP, Blackstone EH.

Eur J Cardiothorac Surg. 2011 Jul;40(1):113-9. doi: 10.1016/j.ejcts.2010.10.020. Epub 2011 Jan 28.

PMID:
21277216
43.

Survival trends in head and neck cancer: opportunities for improving outcomes.

Rodriguez CP, Adelstein DJ.

Oncologist. 2010;15(9):921-3. doi: 10.1634/theoncologist.2010-0237. Epub 2010 Aug 26. No abstract available.

44.

Human papillomavirus: changing paradigms in oropharyngeal cancer.

Adelstein DJ, Rodriguez CP.

Curr Oncol Rep. 2010 Mar;12(2):115-20. doi: 10.1007/s11912-010-0084-5.

PMID:
20425596
45.

A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer.

Rodriguez CP, Adelstein DJ, Rice TW, Rybicki LA, Videtic GM, Saxton JP, Murthy SC, Mason DP, Ives DI.

J Thorac Oncol. 2010 Feb;5(2):229-35. doi: 10.1097/JTO.0b013e3181c5e334.

46.

Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction.

Adelstein DJ, Rice TW, Rybicki LA, Saxton JP, Videtic GM, Murthy SC, Mason DP, Rodriguez CP, Ives DI.

J Thorac Oncol. 2009 Oct;4(10):1264-9. doi: 10.1097/JTO.0b013e3181b26f8e.

47.

Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?

Solares CA, Wood B, Rodriguez CP, Lorenz RR, Scharpf J, Saxton J, Rybicki LA, Strome M, Esclamado R, Lavertu P, Adelstein DJ.

Laryngoscope. 2009 Jun;119(6):1130-4. doi: 10.1002/lary.20225.

PMID:
19358250
48.

Best cases from the AFIP: atypical imaging features of bilateral Achilles tendon xanthomatosis.

Rodriguez CP, Goyal M, Wasdahl DA.

Radiographics. 2008 Nov-Dec;28(7):2064-8. doi: 10.1148/rg.287085001. Review. No abstract available.

PMID:
19001659
49.

Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.

Rodriguez CP, Adelstein DJ, Rybicki LA, Saxton JP, Lorenz RR, Wood BG, Strome M, Esclamado RM, Lavertu P, Carroll MA.

Head Neck. 2008 Dec;30(12):1535-42. doi: 10.1002/hed.20902.

PMID:
18704968
50.

Current and emerging standards of concomitant chemoradiotherapy.

Adelstein DJ, Rodriguez CP.

Semin Oncol. 2008 Jun;35(3):211-20. doi: 10.1053/j.seminoncol.2008.03.004. Review.

PMID:
18544436

Supplemental Content

Loading ...
Support Center